Ever considered UNS now has a boatload more shares on issue?...

First 4 Last

Share
Profile

Follow
oslo

5,687 Posts.

23/02/16

18:49

Post #: 17096479
Share

Originally posted by bourbasted ↑

So just some hindsight here, the delays in announcing this deal, imho, have lead to poor sentiment and heavy scrutiny over the announcement without full comprehension by most of what the deal actually means. This isn't due to silly SH's not getting it, but rather the lack of information re: analysis and word from the business on next steps re: production etc.

This, again imho, is mismanagement and I'm saying this without bias or historical context like so many here have. The impact of delays on announcing to interested parties is often higher levels of pessimism and even when the announcement/information is released it is viewed through tainted glass.

Having read through the deal and being rather short term into this stock, I'm very pleased with the terms, although would be very happy to here from the executive team on next steps very soon. The SP on the ASX is a bit baffling to me, but I believe we are yet to see the net effect of this ann (at least I certainly hope so!).

For the long-termers you have my sincere best wishes in this investment and for the short-termers you probably haven't lost anything and the upside potential over the next few days is pretty big (imho). From what I have read and can see, the deal is solid and the willing association of AMGEN to Unilife is beyond a strong endorsement, it's a binding partnership.

DYOR, IMHO, FWIW, TJAB, blah blah blah.....

Expand

Ever considered UNS now has a boatload more shares on issue? Also it has been reduced to a day traders stock?

UNS Price at posting: 23.5¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

EMD

Emyria's Empax Centre chosen for mental health clinical trial

FHE

Frontier Energy achieves key milestone for Waroona energy project

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

STX

Strike Energy secures $153 million for Perth Basin gas projects

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

BRX

Belararox delineates another porphyry in Argentina at Tambo South